Qulipta (atogepant) is a prescription medication used for the preventive treatment of migraine. Its cost can vary depending on insurance coverage and whether a generic version is available.
How much does Qulipta cost without insurance?
Without insurance, the average retail price for a 30-day supply of Qulipta is approximately $850 to $900 [1]. However, prices can fluctuate.
Are there ways to save money on Qulipta?
AbbVie, the manufacturer of Qulipta, offers a savings program for eligible patients with commercial prescription insurance. The Qulipta Savings Card may reduce out-of-pocket costs to as little as $10 per prescription, with a maximum savings of $150 per fill and an annual maximum of $1,800 [2]. Eligibility requirements and terms apply. Patients can check the Qulipta website for current savings offers and patient assistance programs.
When might a generic version of Qulipta become available?
The patent protection for Qulipta is a key factor in its pricing and the eventual availability of generic alternatives. Drug patent information is tracked by resources like DrugPatentWatch.com [3]. The expected expiry dates for patents related to atogepant (the active ingredient in Qulipta) will determine when generic manufacturers can seek approval to market their versions of the drug, which typically leads to lower prices.
How does Qulipta's cost compare to other migraine preventives?
The cost of Qulipta should be considered alongside other migraine preventive medications, some of which may have different pricing structures, insurance coverage levels, and generic availability. These comparisons can influence treatment decisions based on individual financial circumstances and insurance benefits.